The outcomes in bladder cancer treated with radiotherapy are suboptimal. Recently, Hoskin et al. reported improved survival in patients with bladder cancer treated with radiation therapy with concurrent hypoxia-modification therapy. These results are promising but must be viewed in the context of previous studies and alternative treatment approaches.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ott, O. J. et al. Radiochemotherapy for bladder cancer. Clin. Oncol. (R. Coll. Radiol.) 21, 557–565 (2009).
Kaanders, J. H., J. Bussink, J. & van der Kogel, A. J. Clinical studies of hypoxia modification in radiotherapy. Semin. Radiat. Oncol. 14, 233–240 (2004).
Sealy, R., Cridland, S., Barry, L. & Norris, R. Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 12, 1343–1346 (1986).
Hoskin, P. J., Rojas, A. M., Bentzen, S. M. & Saunders, M. I. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma. J. Clin. Oncol. 28, 4912–4918 (2010).
Milosevic, M. et al. Radiotherapy for bladder cancer. Urology 69 (1 Suppl.), 80–92 (2007).
Pos, F. & Remeijer, P. Adaptive management of bladder cancer radiotherapy. Semin. Radiat. Oncol. 20, 116–120 (2010).
Chai, X. et al. Behavior of lipiodol markers during image guided radiotherapy of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 77, 309–314 (2010).
Pos, F. et al. Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer. Radiother. Oncol. 93, 364–367 (2009).
Rödel, C. & Sauer, R. What is the role of radiotherapy in bladder-preserving cancer therapy? Nat. Clin. Pract. Oncol. 2, 4–5 (2005).
Coppin, C. M. et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 14, 2901–2907 (1996).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Gospodarowicz, M. Hypoxia modification with radiotherapy for bladder cancer. Nat Rev Clin Oncol 8, 129–130 (2011). https://doi.org/10.1038/nrclinonc.2011.5
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2011.5
